Physician profile
Antonio Cusano
NPI 1346746161
$25,391.90
in general payments reported to CMS, 2019-2025
12 companies · $6,299 in 2025
The $6,299 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,200 · 2023: $8,664 · 2024: $9,229 · 2025: $6,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,428 · Education: $6,786 · Grant: $6,786 · Food and Beverage: $3,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,427.86 |
| Education | $6,785.71 |
| Grant | $6,785.71 |
| Food and Beverage | $3,192.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18,337.60 | 2023-2025 | Acufex Meniscal Root Repair, Healicoil, Microraptor |
| Arthrex, INC. | $2,769.65 | 2024-2025 | |
| Kairos Surgical INC | $1,634.53 | 2022-2025 | |
| Stryker Corporation | $1,348.95 | 2023-2025 | Blueprint Patient Specific Instrumentation, Salvation, Aequalis Flex Revive |
| Coastal Technology Solutions LLC | $524.53 | 2025 | |
| Depuy Synthes Sales INC. | $381.74 | 2024-2025 | Dynacord, Hammerlock, Unium |
| Suvon Surgical LLC | $171.23 | 2024 | |
| Exactech, INC. | $112.66 | 2023 | |
| Medical Device Business Services, INC. | $45.62 | 2025 | Na |
| Linvatec Corporation | $25.41 | 2025 | Biobrace 23mm |
| Vericel Corporation | $20.64 | 2024 | Maci |
| Evolution Surgical, INC | $19.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Cusano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.